By Denny Jacob
MeiraGTx Holdings shares rose 13% in premarket trading on a collaboration with Hologen that will bring in a cash infusion and create a joint venture.
Shares were trading around $7.28. The stock is up 8.6% over the last year.
MeiraGTx will receive $200 million as part of the collaboration. The two sides will also form a JV called Hologen Neuro AI, which will be funded with committed of up to $230 million from Hologen to fully finance the development of a treatment for Parkinson's disease, among other efforts.
MeiraGTx will retain a 30% stake in the joint venture and will lead all clinical development and manufacturing.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
March 13, 2025 08:11 ET (12:11 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。